doi: 10.1038/s41575-019-0157-3 31 DaoM
Tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist currently licensed in the UK for type 2 diabetes only
KEY FEATURES (FREE) Shot Logging & Injection Reminders Log weekly or daily doses in seconds Rotate injection sites safely with the site tracker Set custom shot reminders so you never miss a dose Dosage calculator: work out exactly how many units to draw Weight Loss Charts & Medication Levels Visualize your weight loss trends across days, weeks, and months See estimated GLP-1 medication levels using PK + step models Supports semaglutide, tirzepatide, and other GLP-1 medicines Symptom & Side Effect Tracking Log nausea, fatigue, appetite changes, headaches, and more Spot patterns and share progress reports with your provider Daily Targets Estimated daily calorie, protein, fiber, and fluid targets, tailored to you Know how much to eat and drink each day while on GLP-1 medication NEW: Maintenance Mode Reached your goal weight
I would like to share my experience at Vitastir
Louis, MO, United States) were grown with 37C, 5% CO 2 and 21% O 2
Tamai I, Ohashi R, Nezu J, et al
